A new option for managing urogenital atrophy in postmenopausal women

Contemporary Ob-Gyn

Volumn 42, Issue SUPPL., 1997, Pages 13-28

  Bachmann, Gloria A ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002864851     PISSN: 00903159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. American College of Obstetrics and Gynecology. Technical Bulletin 1992;166:1
2. Sarrel P: Genital blood flow and ovarian secretions. J Clin Prac Sex 1990;Special Issue:14
3. Notelovitz M: Estrogen therapy in the management of problems associated with urogenital aging: A simple diagnostic test and the effect of the route of hormone administration. Maturitas 1995;22(suppl):S31
4. Utian WH, Schiff I: NAMS - Gallup survey on women's knowledge, information sources, and attitudes to menopause and hormone replacement therapy. Menopause: Journal of the North American Menopause Society 1994;1(1):39
5. Bachmann GA: Urogenital aging: An old problem newly recognized. Maturitas 1995;22(suppl):S1
6. Rosen RC, Taylor JF, Leiblum SR, Bachmann GA: Prevalence of sexual dysfunction in women: Results of a survey study of 329 women in an outpatient gynecological clinic. J Sex Marital Ther 1993;19(3):171
7. Stenberg A, Heimer G, Ulmsten U: The prevalence of urogenital symptoms in postmenopausal women. Maturitas 1995;22(suppl):S17
8. Bachmann GA: Impact of vaginal health on sexual function. J Clin Prac Sex 1990;Special Issue:18
9. Bachmann GA: The estradiol vaginal ring - a study of existing clinical data. Maturitas 1995;22(suppl):S21
10. Henriksson L, Stjernquist M, Boquist L, et al: A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) on postmenopausal women with symptoms and signs of urogenital atrophy. Am J Obstet Gynecol 1996;174(1):85
11. Henriksson L, Stjernquist M, Boquist L, et al: A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy. Am J Obstet Gynecol 1994;171(3):624
12. Vartiainen J, Wahlstrom T, Nilsson C: Effects and acceptability of a new 17β-estradiol-releasing vaginal ring in the treatment of postmenopausal complaints. Maturitas 1993:17;129
13. Smith P: Estrogen and the urogenital tract: Studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring. Acta Obstet Gynecol Scand Suppl 1993;157(72):5
14. Krantz KE: The human vagina. J Clin Prac Sex 1990;Special Issue:4
15. Forsberg JG: A morphologist's approach to the vagina - age-related changes and estrogen sensitivity. Maturitas 1995;22(suppl):S7
16. Leiblum SR, Bachmann GA, et al: Vaginal atrophy in the postmenopausal women. JAMA 1983;249:2195
17. Masters WH, Johnson VE: Human Sexual Response. Boston, Little, Brown, and Co., 1970
18. Tsai CC et al: Vaginal physiology in postmenopausal women: pH values, transvaginal electropotential difference, and estimated blood flow. South Med J 1987;80(8):98744
19. Schmidt G, Andersson SB, Nordle O, et al: Release of 17β-estradiol from a vaginal ring in postmenopausal women: Pharmacokinetic evaluation. Gynecol Obstet Invest 1994;38:253
20. Baker VL: Alternatives to oral estrogen replacement. Obstet Gynecol Clin NA 1994;21(2):271
21. Fraser IS, Ayton R, Farrell E, et al: A multicentre Australian trial of low-dose estradiol therapy for symptoms of vaginal atrophy using a vaginal ring as delivery system. Maturitas 1995;22(suppl):S41
22. Pharmacia. Investigator's Brochure [data on file].
23. Holmgren PA, Lindskog M, von Schoultz B: Vaginal rings for continuous low-dose release of estradiol in the treatment of urogenital atrophy. Maturitas 1993;16:145
24. Johansson CJ, Gunnarsson PO, Schmidt G: Pharmacokinetics of estradiol after application of an estradiol-releasing vaginal ring. Kabi Pharmacia. Scientific Report 20466F.
25. Boman K: Influence of oestrogen on growth of endometrial carcinoma. Anticancer Res 1990;10:173
26. Mishell DR: Vaginal contraceptive rings. Ann Med 1993;25(2):191
27. Ballagh SA, Mishell DR, Jackanicz TM, et al: Dose-finding study of a contraceptive ring releasing norethindrone acetate/ethinyl estradiol. Contraception 1994:50;535
28. Ballagh SA, Mishell DR, Lacarra M, et al: A contraceptive vaginal ring releasing norethindrone acetate and ethinyl estradiol. Contraception 1994;50:517
29. Weisberg E, Fraser IS, Mishell DR, et al: The acceptability of a combined oestrogen/progestogen contraceptive vaginal ring. Contraception 1995:51;39
30. Nachtigall LE: Clinical trial of the estradiol vaginal ring in the U.S. Maturitas 1995;22(suppl):S43